Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
Condition: Psoriatic Arthritis Interventions: Drug: Filgotinib; Drug: Placebo to match filgotinib Sponsors: Gilead Sciences; Galapagos NV Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials